logo
Sign InSign Up

IDEXX LABORATORIES INC (IDXX)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for IDXX, sign up here.

Income Statement

Revenue

$3.7bn

Gross Profit

$2.2bn

Earning before Tax

$1.1bn

Net Income

$845.0m

Net Income Common Shareholders

$845.0m

EPS

10.17

Balance Sheet

Cash

$453.9m

Debt

$1.0bn

Assets

$3.3bn

Liabilities

$1.8bn

Equity

$1.5bn

Enterprise Value

$46.9bn

Cash Flow Statement

Net Cash from Operations

$906.5m

Net Cash from Investing

$-0.1bn

Net Cash from Financing

$-0.4bn

Net Cash Flow

$341.4m

Free Cash Flow

$772.9m

Free Cash Flow per Share

$9.30

Metrics

Price to Equity

54.55

Price to Equity (Damodaran)

54.58

Price to Book

31.05

Net Margin

0.23

Return on Equity

0.72

Return on Sales

0.30

Get immediate access to 5-years of reference grade data for IDXX for free.

Sign up

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Company Info

Industry

Diagnostics & Research

Employees

11,000

Address

One IDEXX Drive
Westbrook, ME 04092
United States

Phone

207 556 0300

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy